Berger M, Pirke K M, Krieg J C, von Zerssen D
Psychiatry Res. 1985 Aug;15(4):351-60. doi: 10.1016/0165-1781(85)90072-1.
Recent studies from different research groups have raised fundamental questions about the postulated specificity of the dexamethasone suppression test (DST) for endogenous depression. Findings in 116 psychiatric inpatients and 24 semi-starved healthy volunteers underline the importance of weight loss as a factor affecting DST results. A study of 160 DSTs in 93 psychiatric inpatients further revealed a significant negative correlation of plasma cortisol and plasma dexamethasone levels 10 hours after oral administration of 1 mg of dexamethasone. These results suggest a decisive effect of the pharmacokinetics of dexamethasone, at least on the 1-mg DST.
不同研究团队近期的研究对假定的地塞米松抑制试验(DST)用于内源性抑郁症的特异性提出了根本性问题。对116名精神科住院患者和24名半饥饿健康志愿者的研究结果强调了体重减轻作为影响DST结果的一个因素的重要性。一项对93名精神科住院患者进行的160次DST研究进一步显示,口服1毫克地塞米松10小时后,血浆皮质醇和血浆地塞米松水平呈显著负相关。这些结果表明地塞米松的药代动力学至少对1毫克DST有决定性作用。